Zuellig Pharma Corporation
Km 14 West Service Road, South Super Highway,
cor Edison Ave., Sun Valley, Paranaque, Metro Manila Orlistat (Xenical), in combination with a mildly hypocaloric diet, is indicated for treatment of obese or overweight individuals with associated comorbidities. Clinical trials have demonstrated that orlistat promotes weight loss, exceeding that achieved with diet alone. Weight loss was apparent within two (2) weeks of initiation of treatment and continued for a duration of six (6) to 12 months, even in individuals who failed to respond to dieting alone. Orlistat was also effective in prevention of weight regain, with approximately half of the patients regaining no more than 25% of lost weight and about half of these regaining no weight or even continuing to lose weight. The recommended dose of Orlistat (Xenical) is one (1) 120 mg capsule with each main meal (during or up to one hour after the meal). Full product information available upon request. For suspected drug adverse reactions, kindly report to [email protected]
